Spondylosis: Clinical Trials

4 trials for Spondylosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 13Unknown 3
Phase 31Unknown 1

Follow Spondylosis: new trials by email Literature Review of Spondylosis trials Research Report on Spondylosis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
ART352-L - Degenerative Spondylolisthesis
Phase 1 / Phase 2UnknownAnkasa Regenerative Therapeutics, Inc.122020-09-302020-10-12
Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion
Dexmedetomidine intervention, Placebo - Spine; Arthrosis, Spondylolysis
Phase 2 / Phase 3UnknownSarah Network of Rehabilitation Hospitals462016-08-012016-08-23
Pilot Study to Assess Safety/Preliminary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery
Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules, Iliac crest autograft - Degenerative Disc Disease, Spondylolisthesis
Phase 1 / Phase 2UnknownBioSurface Engineering Technologies, Inc222008-11-012012-03-09
Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery
Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules, Iliac crest autograft - Degenerative Disc Disease, Spondylolisthesis
Phase 1 / Phase 2UnknownBioSurface Engineering Technologies, Inc242008-11-012012-03-09

Narrower conditions

Spondylolisthesis (4)  ·  Intervertebral Disc Degeneration (3)  ·  Ankylosis (1)  ·  Back Pain (1)  ·  Osteoarthritis (1)  ·  Spondylolysis (1)

Broader conditions

Bone Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Spinal Diseases (4)  ·  Spondylolysis (3)  ·  Arthritis (1)  ·  Joint Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Rheumatic Diseases (1)  ·  Signs and Symptoms (1)

Interventions

Adrenergic alpha-2 Receptor Agonists (1)  ·  Dexmedetomidine (1)

Sponsors

BioSurface Engineering Technologies, Inc (2)  ·  Ankasa Regenerative Therapeutics, Inc. (1)  ·  Sarah Network of Rehabilitation Hospitals (1)

Countries

United States (2)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Brent Atkinson, PhD (1)  ·  David M Hooper, PhD (1)  ·  Luciano P Miranda (1)